Table 1 Baseline characteristics of the study population
Characteristics | All patients | OGTT | |||
|---|---|---|---|---|---|
Normo-glycaemia | Intermediate hyperglycaemia | Diabetes mellitus | P-valuea | ||
Total | 275 | 152 | 90 | 33 | |
Age, mean years [range] | 69.5 [35–89] | 68.0 [35–87] | 71.5 [48–89] | 71.1 [59–88] | 0.01 |
Sex, n (%) | 0.02 | ||||
Female | 74 (26.9) | 51 (33.6) | 15 (16.7) | 8 (24.2) | |
Male | 201 (73.1) | 101 (66.5) | 75 (83.3) | 25 (75.8) | |
Smoking status, n (%) | 0.06 | ||||
Non-smoker | 42 (15.3) | 23 (15.1) | 10 (11.1) | 9 (27.3) | |
Former/current smoker | 221 (80.4) | 123 (80.9) | 77 (85.6) | 21 (63.6) | |
Missing | 12 (4.36) | 6 (3.95) | 3 (3.33) | 3 (9.09) | |
Renal function, n (%) | 0.04 | ||||
Normal (eGFR > 60) | 201 (73.1) | 120 (79.0) | 57 (63.3) | 24 (72.7) | |
Kidney failure (eGFR < 60) | 71 (25.8) | 31 (20.4) | 31 (34.4) | 9 (27.3) | |
Missing | 3 (1.09) | 1 (0.66) | 2 (2.22) | ||
Anemia female, n (%) | |||||
No anemia | 61 (82.4) | 43 (84.3) | 10 (66.7) | 8 (100) | 0.52b |
Female Hb < 11.7 g/dL | 6 (8.11) | 4 (7.84) | 2 (13.3) | 0 | |
Missing | 7 (9.46) | 4 (7.84) | 3 (13.3) | 0 | |
Anemia male, n (%) | |||||
No anemia | 163 (81.1) | 81 (81.2) | 62 (82.7) | 19 (76.0) | 0.81b |
Male Hb < 13.4 g/dL | 29 (14.4) | 16 (15.8) | 9 (12.0) | 4 (16.0) | |
Missing | 9 (4.48) | 3 (2.97) | 4 (5.33) | 2 (8.00) | |
Medical history of CAD, n (%) | 0.34 | ||||
No | 165 (60.0) | 98 (64.5) | 48 (53.3) | 19 (57.6) | |
Yes | 110 (40.0) | 54 (35.5) | 42 (46.7) | 14 (42.4) | |
Affected vascular bed, n (%) | 0.16 | ||||
Carotid | 43 (15.6) | 26 (17.1) | 11 (12.2) | 6 (18.2) | |
Aortic | 59 (21.5) | 30 (19.7) | 23 (25.6) | 6 (18.2) | |
IOD | 50 (18.2) | 35 (23.0) | 9 (10.0) | 6 (18.2) | |
Infrainguinal | 123 (44.7) | 61 (40.1) | 47 (52.2) | 15 (45.5) | |
Fasting glucose, mean mmol/L (SE) | 5.70 (0.05) | 5.27 (0.04) | 5.90 (0.05) | 7.11 (0.24) | < 0.001 |
HbA1c, mean % (SE) | 6.1 (0.03) | 6.0 (0.03) | 6.1 (0.05) | 6.5 (0.13) | < 0.001 |